Xeloda and Interstitial lung disease - from FDA reports


Summary

Interstitial lung disease is found among people who take Xeloda, especially for people who are female, 60+ old , have been taking the drug for 1 - 6 months, also take medication Tykerb, and have Preventive health care. This review analyzes which people have Interstitial lung disease with Xeloda. It is created by eHealthMe based on reports of 28,732 people who have side effects when taking Xeloda from FDA , and is updated regularly.

What to expect?

If you take Xeloda and have Interstitial lung disease, find out what symptoms you could have in 1 year or longer.

You are not alone!

Join a support group for people who take Xeloda and have Interstitial lung disease

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA since 1977. Our tools are simple to use, anonymous and free. Start now >>>

On Aug, 30, 2017

28,732 people reported to have side effects when taking Xeloda.
Among them, 273 people (0.95%) have Interstitial lung disease


Number of reports submitted per year:

Could Xeloda cause Interstitial lung disease?

Time on Xeloda when people have Interstitial lung disease *:

  • < 1 month: 35.95 %
  • 1 - 6 months: 44.44 %
  • 6 - 12 months: 14.38 %
  • 1 - 2 years: 2.61 %
  • 2 - 5 years: 2.61 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Interstitial lung disease when taking Xeloda *:

  • female: 58.33 %
  • male: 41.67 %

Age of people who have Interstitial lung disease when taking Xeloda *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 3.03 %
  • 30-39: 0.87 %
  • 40-49: 7.36 %
  • 50-59: 20.35 %
  • 60+: 68.4 %

Top conditions involved for these people *:

  • Preventive Health Care (26 people, 9.52%)
  • High Blood Pressure (25 people, 9.16%)
  • Rectal Cancer Metastatic (22 people, 8.06%)
  • Pain (19 people, 6.96%)
  • Metastases To Bone (18 people, 6.59%)

Top co-used drugs for these people *:

  • Tykerb (66 people, 24.18%)
  • Avastin (56 people, 20.51%)
  • Herceptin (54 people, 19.78%)
  • Zometa (45 people, 16.48%)
  • Oxaliplatin (32 people, 11.72%)

Top other side effects for these people *:

  • Breathing Difficulty (60 people, 21.98%)
  • Osteonecrosis Of Jaw (34 people, 12.45%)
  • Stomatitis (31 people, 11.36%)
  • Pain (29 people, 10.62%)
  • Osteomyelitis (27 people, 9.89%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Subscribe to the study: get notified of updates to the study.

Do you have Interstitial lung disease when taking Xeloda?

Expand the study to include all drugs with the same ingredients

Interstitial lung disease and drugs with ingredients of capecitabine.

Expand the study to include reports from both FDA and eHealthMe

Interstitial lung disease and Xeloda from FDA and eHealthMe reports

Xeloda

Xeloda has active ingredients of capecitabine. It is often used in breast cancer metastatic. (latest outcomes from Xeloda 29,056 users)

Interstitial lung disease

Interstitial lung disease has been reported by people with rheumatoid arthritis, high blood pressure, preventive health care, lung cancer - non-small cell, breast cancer (latest reports from 30,952 Interstitial lung disease patients).

Browse all side effects of Xeloda

a b c d e f g h i j k l m n o p q r s t u v w x y z

Drugs that are associated with Interstitial lung disease

Interstitial lung disease

Could your condition cause Interstitial lung disease

Interstitial lung disease

Related studies

What would happen?

Forecast new side effects and undetected conditions when you take Xeloda and have Interstitial lung disease.

Questions to the study

More questions >

User reviews to the study

More reviews >